Site Under Construction
- Mar 2, 2023
Expansion Therapeutics Announces Key Additions and Updates to Scientific Advisory Board
- Oct 26, 2022
Expansion Therapeutics Appoints Raymond Kelleher, M.D., Ph.D., to its Board of Directors
- Jan 24, 2022
Expansion Therapeutics Names Sudhir Rao Senior Vice President of Business Development
- Jan 19, 2022
Expansion Therapeutics Appoints Gary Bridger, Ph.D., to its Board of Directors
- Sep 29, 2021
Expansion Therapeutics Raises $80 Million Series B Financing to Treat Neurodegenerative Diseases
- Jun 14, 2021
Expansion Therapeutics Names Mark Ledeboer, Ph.D., Senior Vice President of Drug Discovery
- May 25, 2021
Expansion Therapeutics Announces In-Licensing of Two New Research Programs from Scripps Research...
- May 6, 2021
Expansion Therapeutics Names Valerie Cullen, Ph.D., Senior Vice President of Research
- Oct 5, 2020
Expansion Therapeutics Names Renato Skerlj, Ph.D., Chief Executive Officer and President